Minervax
Lidia has close to 30 years’ R&D experience, with focus on clinical development, both in pharmaceutical companies as in biotech. She spent more than 20 years of her industry career in development of prophylactic vaccines and has led several large phase 3 clinical programs. She holds a Medical Degree from the University of Ghent (Belgium) and is specialized in Pharmaceutical Medicine.
This person is not in any teams
This person is not in any offices
Minervax
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.